Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Francesco Caraglia"'
Autor:
Piera Grisolia, Rossella Tufano, Clara Iannarone, Antonio De Falco, Francesca Carlino, Cinzia Graziano, Raffaele Addeo, Marianna Scrima, Francesco Caraglia, Anna Ceccarelli, Pier Vitale Nuzzo, Alessia Maria Cossu, Stefano Forte, Raffaella Giuffrida, Michele Orditura, Michele Caraglia, Michele Ceccarelli
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Recent studies have highlighted the importance of the cell-free DNA (cfDNA) methylation profile in detecting breast cancer (BC) and its different subtypes. We investigated whether plasma cfDNA methylation, using cell-free Methylat
Externí odkaz:
https://doaj.org/article/b4709ad2f11d40968a2b2c09a3828f5f
Autor:
Marco Bocchetti, Amalia Luce, Clara Iannarone, Lucia Stefania Pasquale, Michela Falco, Chiara Tammaro, Marianna Abate, Maria Grazia Ferraro, Raffaele Addeo, Filippo Ricciardiello, Giovanni Motta, Luca De Stefano, Francesco Caraglia, Anna Ceccarelli, Silvia Zappavigna, Marianna Scrima, Alessia Maria Cossu, Michele Caraglia, Gabriella Misso
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Exosomes are nanosized vesicles released from all cells into surrounding biofluids, including cancer cells, and represent a very promising direction in terms of minimally invasive approaches to early disease detection. They carry
Externí odkaz:
https://doaj.org/article/f90c8968e1724824b54d57ef6c6c9d00
Autor:
Alessandro Ottaiano, Mariachiara Santorsola, Monica Ianniello, Anna Ceccarelli, Marika Casillo, Francesco Sabbatino, Nadia Petrillo, Marco Cascella, Francesco Caraglia, Carmine Picone, Francesco Perri, Roberto Sirica, Silvia Zappavigna, Guglielmo Nasti, Giovanni Savarese, Michele Caraglia
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background TAS-102 (Lonsurf®) is an oral fluoropyrimidine consisting of a combination of trifluridine (a thymidine analog) and tipiracil (a thymidine phosphorylation inhibitor). The drug is effective in metastatic colorectal cancer (mCRC) p
Externí odkaz:
https://doaj.org/article/0cb75c489e0747b7a5a221e4b1270d45
Autor:
Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, Gabriella Suarato, Rossella Napolitano, Alfonso Esposito, Francesco Caraglia, Maria Cristina Giugliano, Eleonora Cioli, Vincenzo Famiglietti, Roberto Bianco, Giuseppe Argenziano, Andrea Ronchi, Davide Ciardiello, Valerio Nardone, Emma D’Ippolito, Sara Del Tufo, Fortunato Ciardiello, Teresa Troiani
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Cemiplimab has demonstrated relevant clinical activity in cutaneous squamous cell carcinoma (cSCC) but mechanisms of primary and acquired resistance to immunotherapy are still unknown. We collected clinical data from locally advanced and/or metastati
Externí odkaz:
https://doaj.org/article/c5266e85e64141d58178111000be05fd
Publikováno v:
Procedia Structural Integrity. 44:902-909